Aristotle Capital Boston LLC Sells 123,119 Shares of Itron, Inc. $ITRI

Key Points

• Aristotle Capital Boston LLC trimmed its Itron stake by 28.9%, selling 123,119 shares and now holds 303,560 shares valued at about $37.8M, making Itron its 10th-largest position.
• Itron beat quarterly expectations with EPS of $2.46 vs. $2.19 and revenue of $571.7M, and provided guidance of Q1 2026 EPS 1.20–1.30 and FY 2026 EPS 5.75–6.25.
• Broader ownership moves: large funds such as Vanguard and Impax materially increased holdings (Impax added 890,040 shares), insiders sold 51,180 shares (~$5.09M) last quarter, and institutional investors own ~96.19% of the stock.

Aristotle Capital Boston LLC trimmed its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 28.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 303,560 shares of the scientific and technical instruments company's stock after selling 123,119 shares during the quarter. Itron makes up about 1.9% of Aristotle Capital Boston LLC's investment portfolio, making the stock its 10th biggest position. Aristotle Capital Boston LLC owned 0.66% of Itron worth $37,812,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Itron by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company's stock worth $731,809,000 after acquiring an additional 132,329 shares in the last quarter. Impax Asset Management Group plc increased its holdings in Itron by 127.3% during the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company's stock valued at $197,153,000 after purchasing an additional 890,040 shares in the last quarter. Geode Capital Management LLC increased its holdings in Itron by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,109,851 shares of the scientific and technical instruments company's stock valued at $146,107,000 after purchasing an additional 21,925 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Itron by 1.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,076,274 shares of the scientific and technical instruments company's stock valued at $134,058,000 after purchasing an additional 16,261 shares during the last quarter. Finally, Handelsbanken Fonder AB raised its position in Itron by 6.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company's stock valued at $124,545,000 after purchasing an additional 56,318 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.

Insider Activity at Itron

In related news, SVP Christopher E. Ware sold 4,486 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total value of $446,536.44. Following the completion of the sale, the senior vice president owned 31,806 shares in the company, valued at $3,165,969.24. This represents a 12.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Donald L. Reeves III sold 5,419 shares of the firm's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $539,407.26. Following the sale, the senior vice president directly owned 33,140 shares in the company, valued at $3,298,755.60. The trade was a 14.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 51,180 shares of company stock valued at $5,085,475. 1.45% of the stock is owned by corporate insiders.

Itron Stock Performance

Shares of NASDAQ:ITRI opened at $90.00 on Friday. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of 13.82, a P/E/G ratio of 0.78 and a beta of 1.44. The firm's 50 day simple moving average is $97.33 and its 200 day simple moving average is $106.71. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. Itron, Inc. has a fifty-two week low of $88.57 and a fifty-two week high of $142.00.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. During the same quarter last year, the firm earned $1.35 EPS. Itron's quarterly revenue was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. As a group, sell-side analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on ITRI. Oppenheimer increased their target price on Itron from $125.00 to $133.00 and gave the stock an "outperform" rating in a report on Wednesday, February 18th. Robert W. Baird set a $128.00 price target on Itron and gave the company an "outperform" rating in a report on Wednesday, February 18th. Johnson Rice upgraded shares of Itron from an "accumulate" rating to a "buy" rating and set a $130.00 price target on the stock in a research report on Monday, January 5th. Needham & Company LLC assumed coverage on shares of Itron in a report on Friday, March 6th. They set a "buy" rating and a $124.00 price objective on the stock. Finally, Guggenheim set a $155.00 price objective on shares of Itron in a report on Friday, February 13th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $137.10.

Itron Company Profile

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.